VP, Market Access
Max Gill has more than 20 years of health economic, health policy, and reimbursement experience in the medical device industry. Before joining Beta Bionics, Mr. Gill led Health Economics & Reimbursement teams at Medtronic Diabetes, Covidien (Surgical Division), and Cyberonics. Prior to that, he spent six years working at Blue Cross Blue Shield in Kansas City. At Beta Bionics, Mr. Gill is a subject matter expert in market access and reimbursement who provides strategic insight and planning aimed at ensuring rapid and comprehensive access for the launch of the Company’s first product following FDA clearance. He holds an MBA degree and a BA degree in management from Southeastern Louisiana University, as well as a Bachelor of Commerce degree in cost accounting from Punjab University in India.